General Information
Revision date
2008-03-28
Product name
Herceptin Intravenous
Product Synonyms
Not available
Chemical name
Not applicable
1.2.1 Relevant identified uses
Pharmaceutical product Classification Antineoplastic Agent
supplier name
Wyeth
Emergency telephone
1-610-688-4400, 1-800-424-9300, 1-703-527-3887
Icons in SDS
Company Information
company name
Wyeth
Section 2
SECTION 2: Hazards identification
Trastuzumab 180288-69-1 None assigned 440 mg/vial None assigned 3. HAZARDS IDENTIFICATION Emergency Overview This contains an active pharmaceutical ingredient that can affect body functions; handle with caution. Appearance Pharmaceutical powder Physical State Solid Odor Not available Potential Physical Hazards Powders and solids are presumed to be combustible. Potential Health Effects Eyes May cause mechanical eye irritation. Skin Not available Inhalation Not available Ingestion The most common effects may include fast or irregular heartbeat, cough increase, shortness of breath, swelling of feet or lower legs, unusual weakness, mild diarrhea, nausea, pain, vomiting, allergic reactions, angioedema, urticaria, Adult Respiratory Distress Syndrome (ARDS), bronchospasm, anemia, difficult or labored breathing, tightness of chest, hypotension, fever or chills, hoarseness, lower back pain, chest pain, difficult, fast, noisy breathing, pulmonary infiltrates, trouble in sleeping, loss of appetite, numbness or tingling of hands or feet, runny nose, and skin rash. Please see Patient Package Insert for further information. Therapeutic Target Organ(s) Systemic. Not listed by OSHA, NTP or IARC. Potential Environmental Effects There is no known ecological information for this product.
